- Home
- PCRX vs CGNT Comparison
PCRX vs CGNT Comparison
Compare PCRX & CGNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- CGNT
- Stock Information
- Founded
- PCRX 2006
- CGNT 2020
- Country
- PCRX United States
- CGNT Israel
- Employees
- PCRX N/A
- CGNT N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- CGNT Computer Software: Prepackaged Software
- Sector
- PCRX Health Care
- CGNT Technology
- Exchange
- PCRX Nasdaq
- CGNT Nasdaq
- Market Cap
- PCRX 1.2B
- CGNT 669.2M
- IPO Year
- PCRX 2011
- CGNT N/A
- Fundamental
- Price
- PCRX $23.22
- CGNT $8.93
- Analyst Decision
- PCRX Buy
- CGNT Hold
- Analyst Count
- PCRX 8
- CGNT 1
- Target Price
- PCRX $28.38
- CGNT N/A
- AVG Volume (30 Days)
- PCRX 569.8K
- CGNT 450.8K
- Earning Date
- PCRX 07-29-2025
- CGNT 06-11-2025
- Dividend Yield
- PCRX N/A
- CGNT N/A
- EPS Growth
- PCRX N/A
- CGNT N/A
- EPS
- PCRX N/A
- CGNT N/A
- Revenue
- PCRX $702,772,000.00
- CGNT $363,466,000.00
- Revenue This Year
- PCRX $7.54
- CGNT $14.94
- Revenue Next Year
- PCRX $10.78
- CGNT $9.57
- P/E Ratio
- PCRX N/A
- CGNT N/A
- Revenue Growth
- PCRX 3.08
- CGNT 12.58
- 52 Week Low
- PCRX $11.16
- CGNT $6.21
- 52 Week High
- PCRX $27.64
- CGNT $11.66
- Technical
- Relative Strength Index (RSI)
- PCRX 35.42
- CGNT 41.91
- Support Level
- PCRX $22.82
- CGNT $9.08
- Resistance Level
- PCRX $24.36
- CGNT $9.49
- Average True Range (ATR)
- PCRX 0.69
- CGNT 0.30
- MACD
- PCRX -0.12
- CGNT -0.02
- Stochastic Oscillator
- PCRX 17.09
- CGNT 49.13
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
About CGNT Cognyte Software Ltd.
Cognyte Software Ltd provides security analytics software that empowers governments and enterprises with Actionable Intelligence. Its interface software is designed to help customers accelerate and improve the effectiveness of investigations and decision-making.